WHO backs GLP-1 treatments to tackle obesity epidemic
The World Health Organization has unveiled new recommendations indicating that revolutionary weight-loss drugs could play a vital role in addressing the escalating obesity epidemic. Specifically, GLP-1 agonist therapies are suggested for long-term obesity care in adults.
17 C